Member Info for Qd22

I wasn't too happy with the Cash ISA aspect before.... now I'm kinda glad!

Goodness, they're going to have some firepower: when the time is right. If Itaconix is going the way of all flesh, simply because they can't raise the needed ongoing funding for a great business, I wonder if they would consider stepping in?! There'll be others like them.

Dream on, Qd.

The problems causing this fall will continue for quite some time, and may get much worse. They may cause other problems: for example they have already caused the oil-price to collapse, and a recession now looks quite likely. There could be more. I think everything could have further to fall, and when things begin to recover it will not be quick. TSTL being what it is makes things even more complicated here. I agree it’s the last share you would expect to have seen fall.

IMO, of course. DYOR: or rather MYOG - Make Your Own Guess. That’s really what it feels like: experienced guesswork.

Take care everyone, and all the best.

Got your update! Not the greatest, and on one of the worse days of stockmarket history.

Down 13.3% on net sales of just £1,575! But today it's not surprising. However the need now for remote working may energise that side of things, and Simigon's VR offering may find much wider applications in that environment than it does now.

In time, and maybe at a great price, the virus will be overcome or at least brought down to a much lower level. But the necessity for isolation and working from home may change many working practices, especially in view of the even greater problem of climate change. Perhaps after this there will be more willingness to face the facts and bite the necessary bullets on climate change, and VR may be part of the technological solutions.

Agreed. For some incredible reason no one has been taking it seriously. CHINA has bought us time but it’s all been wasted with no one getting their heads around it. Only just now beginning to happen.

Anyone know who these Brierwoods are, apart from "significant shareholders"?

On the rise again. No wonder, I suppose. Lord...!

I see the directors have been altering their holdings/cashing in a little. Can't blame Paul Barnes with nearly £2m worth in one stock. Bought a nice car? But in the main they're holding.

"Haydale has supplied graphene to iCraft since May 2019 for development work in a number of areas including cosmetic use. iCraft, based in South Korea, is a global technology company with interests in security and network solutions as well as the health and beauty sector. Following intense research and rigorous testing, iCraft is pleased to report zero harmful substances for graphene-based products, and has applied for three related patents.

Whilst the initial volume of graphene required to meet early stage demand may not be significant, this marks a significant step-change in the use of the material, which is now being used in applications that directly touch the skin."

I like this, just wonder where it could lead. Skin cosmetics are huge in the Far East, and they are very particular. What could this mean for clothing? It's finding uses in more and more fields, and Haydale are supplying.

Rivaldo, are you still watching/in this one? What do you think?

Additional to earlier comments: post period-end the tie up with BigCommerce looks good, ditto the 3 year renewal of contract with their largest client. One expands their potential customer base and the other shows the confidence their customers have in their product. :). Seems to be a case of 'try it, you'll like it'.

Results out today, causing a 15% drop. But they look very good to me, except that there is a warning that the next year may be a bit slow: "Macro-economic and political uncertainty headwinds in the latter part of 2019 impacted our H2-2019 bookings and hence our 2019 ARR exit rate. We entered 2020 with a strong pipeline of new opportunities but have been unable to accelerate the close of sufficient deals in January and February to offset the H2-2019 bookings shortfall. Whilst we continue to be comfortable with our expectations for new bookings in 2020, with c. 20% year on year growth, given the revenue recognition profile of SaaS deals we are prudently reducing our market expectations for the full year at this early stage.". Given the other metrics I don't think the drop is justified and have topped up. Loads of new logos (22), 98% retention rate, high and improving margins, revenue almost all SaaS, 21 multi-year renewals (2018: 10). With the retention rate, revenue increase (13%), margin increase (6% pts to 73%), and multi-year renewals short of an upset I think it only needs time for this to come good. Good news post period-end too. Today looks a good entry point and while it may be slow for a year when it goes it may fly.

Topped up. This share is way under the radar, and a big spread, but bought at a full 1p less than the quoted buy price. But at 70m Mcap I have some much smaller shares. Maybe they should put a little more effort into marketing themselves!

I looked hard at topping this up when it was well down in the 300's, but I had topped up twice before, and am still holding all of them. Glad to see it rise, but then it got caught in the Covid-19 wind, along with everything else. My concern now is that the cruise liner side of the business will take a hit, along with all amusement parks and others. The drop so far at over 25% is heavy, but not as exaggerated as I would have expected given ACSO's history and business. I also wonder if the parks and cruise liner businesses will take a longer time than most to recover: we're all doubly protective of our children, and the liners have proved to be a scary proposition recently. Older people especially will now think twice and thrice before committing to a cruise. Bognor & Skeggy, here we come!

I'm not selling as I don't like to trade (or have the confidence), and the uses of this tech may spread further. I would love to hear an update on how it has worked out in the hospital that tried it. But writing this has persuaded me not to jump in quickly. ATB, all.

Yes, this is a really useful article, as long as we can trust what Marom tells his home newspaper:

'As the CEO of the company Dr. Zvi Marom explained to The Jerusalem Post, compared to the kit that is currently used by hospitals all over the world, the product conceived by BATM has the advantage of being faster and more accurate and, within a few weeks, the company aims to set the cost at approximately NIS 1 per test. The kit is expected to be CE approved next week....

...For the past nine years, BATM has been working with leading research institutions in several countries to develop an innovative diagnostic device to identify any kind of pathogen in less than half an hour.
“We built a machine that looks like a shoe box in which cartridges containing between 100 and 200 pathogens are inserted according to the suspected disease: we have created a hospital admission cartridge, a respiratory cartridge, a meningitis cartridge, and so on,” Marom explained.
The system is currently being tested in hospitals.
“We believe that this will mark a very big change in how people are diagnosed and treated for infectious diseases,” he pointed out.
It was in this scenario that the coronavirus emergency arose.
“We got reports about the virus from our Chinese colleagues very early on and started to monitor the situation, even receiving from them the sequence of the virus. We understood immediately that we were looking at a cousin of the SARS and the MERS diseases and we began to prepare,” he told the Post.
In order to face the emergency, the company decided to use the research to develop a specific kit for the coronavirus family of diseases, creating one that supports all the directives of the Centers for Disease Control and Prevention (CDC) and is completely compatible with the equipment currently available in hospitals.
“We basically took what we had in our research about the SARS and the MERS. We added to them the COVID-19 and developed a new kit just for these three diseases that can be used with existing hospital equipment i.e. RT-PCR,” Marom explained.
“All they need from us is a special kind of small tube,” he added.
The CEO highlighted that the BATM kit has a number of advantages, among them the fact that is faster than the more common one, and most importantly that it reduces the number of false positive results, meaning the number of people who are diagnosed with the coronavirus but are not really infected.
He also said that they are already working with several partners, including with government-related institutions in Israel and in Italy, in order to manufacture the kits in large quantities and make them very affordable.
The company has commenced the production of the kit at its Adaltis facility in Rome.'

Presently 1 NIS (Israeli New Shekel) is currently worth 22p.

Yes, I like the interview too. He makes a good case for the complementary combination of VENN & HVIVO, and the financial case with or without the covid virus. Plus I like the way he himself comes across, realistic, and prepared to admit where they've been lucky. And a lot of skin in the game. Topped up: I hope - it is not on the deal list.

Thanks Gotrader. I always read your posts with interest. Going by memory last time I looked at it carefully I thought we would just be blowing in the wind at least until the half-year results. Now it looks as if those are going to be very dicey. Perhaps we are already paying the price. The virus thing will eventually work through, though it could take years. Being honest the question in my mind is when it does will IQE still have the technological edge that it did before.

This is the link, it is well worth reading, and encouraging:

https://hbr.org/2020/02/we-need-a-cheap-way-to-diagnose-coronavirus

Well I'm certainly not going to sell! :)

The question in my mind is how quickly they can get this out effectively and at scale, in either format. CEO Marom's view: "We are able now to quickly provide diagnostic kits for any new pathogen that appears." What is the timescale "to progress the kit to make it at a price point suitable for large scale production"? That's what we all need to know, investors and non-investors alike.

"The Group has commenced production of the kit at its Adaltis facility in Rome. BATM is working with academic and research institutions, mainly in Europe, to progress the kit to make it at a price point suitable for large scale production. The kit, which supports all the Centers for Disease Control and Prevention (CDC) recommendations, has already received interest from customers in several countries.

In addition, COVID-19 will be included within the Ador suite of testing kits as part of its travel panels. Laboratory bench tests are expected to commence imminently."

Background info re Ador that MickT posted a few weeks back:
https://investegate.co.uk/batm-advanced-comm--bvc-/rns/first-commercial-agreement-for-ador/202001070700059134Y/

Thanks for your posts, Nicton. I'm considering this, though not till the markets have quietened down a bit, and it's helpful that there are some signs of life - and informed posts with a long term perspective to boot. ATB

Agreed. A lot of shares have rallied following the rout this morning, with buy volumes greater than sales, in spite of the fall in the share price. But I think the news will get worse and at that point those who have bought in today or earlier will not buy again. So I am afraid there is further to fall for the general market, and more grief for everyone.... while Tristel will continue its rise. My guess.

Finally some movement. But there is still a lot of cash. It’s a bit of a widespread for a bank account.

Bought in this afternoon, sat down to write some notes on why (always forget!) - and realised the case is even stronger and I should've bought more. Had to go back again. Btw, the 1st buy is showing as a sell.